Aqua Phase

Premium

Finance

Gibraltar-Based Firm Acquires Bod Science's Low-Dose CBD Trial Data and IP Assets

January 30, 2025

Premium

Finance

Biortica Agrimed Eyes ASX Entry Through Bod Science Acquisition

March 21, 2024

Premium

Finance

Bod Science Secures Supply Agreement With Green Farmers as Creditor Claims Top A$6m

December 13, 2023

Finance

Bod Science prepares capital raise amid falling revenues and broader product pipeline

October 31, 2023

Medical

Bod Science's Aqua Phase technology clears second bioavailability hurdle, opening doors beyond cannabis

September 27, 2023

Premium

Finance

Bod Science charts path to new revenue as losses climb to A$8 million

August 30, 2023

Premium

Medical

Bod Science hails 'exciting new chapter' as Aqua Phase technology clears absorption milestone

July 26, 2023

Premium

Medical

Bod Science expands Aqua Phase technology into psychiatric and neurological drug treatments

May 31, 2023

Medical

Bod Science Eyes Commercial Future for Aqua Phase as Second PK Study Gets Green Light

May 23, 2023

Finance

Bod Science submits ethics approval for bioavailability study

March 28, 2023

Finance

Bod Science meets stability conditions for Aqua Phase acquisition but pharmacokinetic study pushed back

March 07, 2023

Finance

Bod Science CBD Revenue Drops 29% as THC Flower Demand Grows

February 27, 2023

Medical

Bod Australia CEO sees major revenue opportunity in CBD bioavailability technology deal

October 13, 2022